Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
67.60
+2.32 (3.55%)
At close: Jan 21, 2026, 4:00 PM EST
67.53
-0.07 (-0.10%)
After-hours: Jan 21, 2026, 6:52 PM EST

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jan '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2016 - 2020
9,2904,7692,4082,8803,4986,509
Upgrade
Market Cap Growth
279.95%98.03%-16.40%-17.67%-46.25%47.77%
Upgrade
Enterprise Value
9,1174,5882,4362,7993,1836,017
Upgrade
Last Close Price
67.6034.4919.3726.8733.0562.43
Upgrade
PS Ratio
10.905.75678.1211.9614.3847.07
Upgrade
PB Ratio
19.689.4712.6010.038.3615.92
Upgrade
P/TBV Ratio
20.2310.3913.6111.039.0516.47
Upgrade
P/FCF Ratio
59.2230.40---44.06
Upgrade
P/OCF Ratio
51.7426.56---37.99
Upgrade
EV/Sales Ratio
10.995.53686.0211.6313.0943.51
Upgrade
EV/EBITDA Ratio
74.5637.52----
Upgrade
EV/EBIT Ratio
92.7046.65----
Upgrade
EV/FCF Ratio
58.1129.25---40.72
Upgrade
Debt / Equity Ratio
1.481.484.461.340.200.06
Upgrade
Debt / EBITDA Ratio
5.365.36----
Upgrade
Debt / FCF Ratio
4.744.74---0.17
Upgrade
Asset Turnover
0.660.660.000.330.350.22
Upgrade
Quick Ratio
4.734.736.573.752.672.58
Upgrade
Current Ratio
4.864.866.743.952.922.63
Upgrade
Return on Equity (ROE)
8.67%8.67%-254.98%-59.33%-42.68%-32.36%
Upgrade
Return on Assets (ROA)
4.87%4.87%-39.43%-17.58%-15.91%-15.11%
Upgrade
Return on Invested Capital (ROIC)
17.11%16.53%-187.71%-101.05%-180.86%-127.38%
Upgrade
Return on Capital Employed (ROCE)
8.30%8.30%-58.00%-31.10%-32.30%-26.40%
Upgrade
Earnings Yield
-0.02%-0.03%-24.90%-7.13%-5.03%-2.16%
Upgrade
FCF Yield
1.69%3.29%-25.10%-11.48%-5.40%2.27%
Upgrade
Buyback Yield / Dilution
-11.67%-11.67%-12.21%-1.26%-1.62%-3.00%
Upgrade
Updated Nov 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q